NCT04267861View on ClinicalTrials.gov

M7824 Related Adverse Effects in Adults With Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

232

Participants

Timeline

Start Date

January 28, 2020

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
NeoplasmsSkin Neoplasms
Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT04267861 - M7824 Related Adverse Effects in Adults With Cancer | Biotech Hunter | Biotech Hunter